Track topics on Twitter Track topics that are important to you
Graphene oxide (GO) was introduced to Enterococcus avium strain BY7 sulfate-reducing bacteria culture as a carrier, GO was partially reduced by SRB to reduced graphene oxide (rGO). The rGO could further self-assemble Enterococcus avium strain BY7 sulfate-reducing bacteria to form BY-rGO particles. Growth and sulfate reduction activity of strain BY7 was promoted by rGO, which probably due to the protective effect of rGO, and enhanced electron transfer by rGO as electron shuttle. Effects of pH and temperature variance on strain BY-rGO were remarkably weakened, growth and sulfate reduction were observed from pH 2.0 to 12.0, and from 10 to 45 °C, respectively. Metal toxicity to BY7 strain SRB was sharply decreased in BY-rGO particles and heavy metal removal was remarkably accelerated (up to 50%). The immobilization methods established in this study might open a new way for the application of SRBs, especially under extreme environmental conditions.
This article was published in the following journal.
Name: Bioresource technology
One of the major challenges encountered in some conventional nano-structured adsorbents such as graphene oxide (GO) and graphene is the structural limits including serious aggregation and hydrophilic ...
We have successfully synthesized the composites of two-phase g-CNheterojunction photocatalysts by one-step method. And the reduced graphene oxide/two-phase g-CNheterojunction photocatalyst was fabrica...
Low electrode resistance is crucial for achieving efficient reactions in bio-electrochemical system (BES), especially considering the factors of BES scaling-up and microbial effects. Graphene has reve...
A facile one-pot method for the formation of MoO/RGO has been established using Mo particles as both the reductant for graphene oxide (GO) and as the Mo source. The Mo powder efficiently reduced the G...
We present a method for reduced graphene oxide patterning on the surface of graphene oxide film by 445 nm solid-state laser with the adjustable fluence from 0.2 to 20 kJ/cm<sup>2</sup>. We...
Lidocaine patch is a safe and effective topical anesthetic agent for removal of metal staples after total knee replacement
To determine if the subject metal reduction software helps to better visualize bone interphase and fusion reliability, and assess whether the appropriate procedural modification facilitate...
This is a multi-center, randomized study to compare blood and urine cobalt, chromium, and titanium ion levels of a metal-on-metal articular bearing coupled with two different head sizes to...
The aim of this study is to demonstrate the non-inferiority of the ceramic-on-metal articulation using large diameter bearings (38mm to 60mm) compared to the metal on metal articulation us...
A clinical Evaluation to determine metal ion release from 4th generation metal-on-metal hip articulating surfaces in cementless total hip arthroplasty.
Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate.
An enzyme that catalyzes the activation of sulfate ions by ATP to form adenosine-5'-phosphosulfate and pyrophosphate. This reaction constitutes the first enzymatic step in sulfate utilization following the uptake of sulfate. EC 22.214.171.124.
An arylsulfatase that catalyzes the hydrolysis of the 4-sulfate groups of the N-acetyl-D-galactosamine 4-sulfate units of chondroitin sulfate and dermatan sulfate. A deficiency of this enzyme is responsible for the inherited lysosomal disease, Maroteaux-Lamy syndrome (MUCOPOLYSACCHARIDOSIS VI). EC 126.96.36.199.
An enzyme that specifically cleaves the ester sulfate of iduronic acid. Its deficiency has been demonstrated in Hunter's syndrome, which is characterized by an excess of dermatan sulfate and heparan sulfate. EC 188.8.131.52.
Aluminum metal sulfate compounds used medically as astringents and for many industrial purposes. They are used in veterinary medicine for the treatment of ulcerative stomatitis, leukorrhea, conjunctivitis, pharyngitis, metritis, and minor wounds.